Finished product reference
Ringers
Injection, Solution · Intravenous · 147 mEq/4.5 mEq/4 mEq/156 mEq/1L · 250 mL
- List code
- 6423
- Pharmacologic class
- Intravenous crystalloid (isotonic electrolyte solution)
What it is and how it works
Ringer’s solution contains sodium chloride with small amounts of potassium chloride and calcium chloride, in concentrations approximating those of extracellular fluid but without a bicarbonate precursor. It restores extracellular fluid volume and electrolytes.
Indications
Replacement of extracellular fluid and electrolyte losses, particularly with hypochloraemia (e.g. vomiting); vehicle for compatible intravenous medicines.
Dosage and administration (summary)
Given by intravenous infusion; volume and rate are individualised according to age, weight, clinical condition, fluid balance and electrolytes.
Contraindications
Fluid overload, hyperkalaemia, hypercalcaemia, hyperchloraemia and severe hypernatraemia; concurrent ceftriaxone infusion in neonates.
Warnings and precautions
Monitor fluid balance and electrolytes, and use with caution in heart failure, renal impairment and oedema. Large volumes may cause hyperchloraemic acidosis; because it contains calcium, avoid administration through the same line as blood or ceftriaxone.
Pregnancy
May be used in pregnancy with fluid balance monitoring.
Storage and supply
Store below 25 °C; do not freeze; use only if the solution is clear and the container undamaged.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.